CN Stock MarketDetailed Quotes

002773 Chengdu Kanghong Pharmaceutical Group

Watchlist
  • 19.99
  • -0.50-2.44%
Market Closed Dec 13 15:00 CST
18.39BMarket Cap15.41P/E (TTM)

Chengdu Kanghong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Biological drugs1.17B51.15%
Chinese patent medicine749.98M32.69%
Chemical drugs359.35M15.66%
medical apparatus8.35M0.36%
Other2.23M0.10%
Other business797.2K0.03%
View all
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical manufacturing2.29B99.97%
Other business797.2K0.03%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China604.77M26.36%
South China594.51M25.91%
Southwest412.74M17.99%
North China303.59M13.23%
Northwest206.27M8.99%
Northeast China157.73M6.88%
Overseas13.72M0.60%
Other business797.2K0.03%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%